The White House on Wednesday unveiled its plan to roll out COVID-19 vaccines for kids ages 5 to 11, pending the vaccine’s approval by the U.S. Meals and Drug Administration (FDA).
“In anticipation of the FDA’s impartial advisory committee assembly on October 26 and the CDC’s (the U.S. Facilities for Illness Management and Prevention) impartial advisory committee assembly on November 2 to three, right now the Biden Administration is asserting a plan to make sure that, if a vaccine is permitted for kids ages 5 to 11, it’s shortly distributed and made conveniently and equitably obtainable to households throughout the nation,” the White House introduced in an announcement.
The beginning of a vaccination program for kids ages 5 to 11 will depend upon the impartial FDA and CDC course of and timeline, mentioned the White House, including the nation shall be prepared to start getting pictures in arms within the days following a last CDC suggestion.
The Biden administration has procured sufficient vaccine to help vaccination for the nation’s 28 million kids ages 5 to 11 years previous, in keeping with the White House.
White House coronavirus coordinator Jeffrey Zients mentioned Wednesday the Biden administration was aiming to “plan forward in order that we are able to hit the bottom operating,” however that specialists on the FDA and CDC would have the ultimate say.
Vaccine advisers to the FDA are scheduled to satisfy subsequent week to debate information concerning the security and efficacy of the Pfizer-BioNTech pediatric vaccine.
If licensed by the FDA, the Pfizer-BioNTech vaccine could be the primary COVID-19 vaccine for youthful kids.
A CDC vaccine advisory panel is scheduled to satisfy on Nov. 2 and three to weigh a suggestion to be used. If the CDC director indicators off on a suggestion to be used, the vaccine might be administered to kids ages 5 to 11.
The Pfizer-BioNTech vaccine is at the moment totally authorized for folks age 16 and older, and has emergency use authorization from the FDA for kids ages 12 to fifteen.
Pfizer mentioned final month {that a} Part 2/3 trial confirmed its COVID-19 vaccine was secure and generated a “sturdy” antibody response in kids ages 5 to 11.
The trial included 2,268 members ages 5 to 11, and used a two-dose routine of the vaccine administered 21 days aside. This trial used a 10-microgram dose, which is smaller than the 30-microgram dose that has been used for these ages 12 and older.
Discussion about this post